Berberis Aristata and Metformin in Diabetic Patients
Phase 1
- Conditions
- Diabetes Mellitus.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20230202057310N3
- Lead Sponsor
- Muhammad Institute of Medical and Allied Sciences, Multan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 295
Inclusion Criteria
Age group of 25-70 years
Both Genders (Male, Female)
Married and unmarried
Educated and uneducated
Diabetic patients
Exclusion Criteria
Any type of mental disability
Lactating females
Having any type of physical disability
History of chest pain
bronchitis
Any type of major surgery
Pregnant females
Asthma
Angina
MI Chronic illness related to cardiorespiratory ailments
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glucose level in diabetic patients. Timepoint: 6 weeks. Method of measurement: Blood glucose level by glucometer.;Cholesterol level. Timepoint: 6 weeks. Method of measurement: Lipid profile meter.;HbA1C. Timepoint: 6 weeks. Method of measurement: Blood sampling.
- Secondary Outcome Measures
Name Time Method Cardiorespiratory parameters. Timepoint: 6 weeks. Method of measurement: Pulse oximeter, Manometer for blood pressure monitoring.